NICE

Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.

[NICE @NICEComms]

We’ve recommended tisotumab vedotin for advanced cervical cancer. It belongs to a class of medicines called antibody-drug conjugates, which target and deliver cancer-killing medicine directly to tumour cells.

Read the final guidance here: https://t.co/W4vPtnJiEg

[NICE @NICEComms]

This morning, our programme director for healthech strategy and development, Sarah Byron, was discussing AI at #NHSConfed2026.

Sarah was joined on a panel talking about the AI shift in urgent diagnostics.

#NHSConfedExpo

[NICE @NICEComms]

Our programme director for healthech strategy and development, Sarah Byron, joined a panel this afternoon at #NHSConfed2026.

Sarah was talking about turning the National Cancer Plan into UK cancer outcomes.

#NHSConfedExpo

[NICE @NICEComms]

NICE healthtech director Thomas Slater is on the panel at #NHSConfed2026, exploring how innovation moves from research to real-world NHS adoption.

👉Developing or adopting healthtech? Explore support:
https://t.co/TxBXYhtPAr

#BackingTheHealthtechThatChangesLives #HealthTech

[NICE @NICEComms]

Our programme director for medicines evaluation, Jacoline Bouvy, discussing medicines policy in the new NHS operating model and what this means for organisations across health and social care.

Jacoline is one of four of our experts joining panels at #NHSConfed2026

[NICE @NICEComms]

We're delighted to be at #NHSConfed2026

Come and talk to us about how NICE guidance can support your organisation - you'll find us at stand B19.

You can also hear from our experts who are on 4 panels over the 2 days.

[NICE @NICEComms]

Heading to #NHSConfed2026 this week?

Our experts will be on two panels on day 1 — covering medicines policy in the new NHS operating model and how innovation gets from research to real-world adoption.

Come and find us at stand B19.

[NICE @NICEComms]

This #DiabetesAwarenessWeek, meet Aleix.

T1D meant constant calculations and saying no to life.

A hybrid closed loop device changed everything: less worry, better sleep, more freedom.

https://t.co/3GXdtezzXK

👉Explore healthtech support: https://t.co/TxBXYhtPAr

[NICE @NICEComms]

Today, NICE has published guidance recommending daratumumab with bortezomib, lenalidomide and dexamethasone as an option for people with untreated multiple myeloma when a stem cell transplant is unsuitable.

Read the final draft guidance here: https://t.co/VtlsNFDOK5

[NICE @NICEComms]

🎧NEW NICE Talks: Treating babies at home with oral antibiotics.

New NICE guidance could mean shorter hospital stays for some newborns - by switching to oral antibiotics at home.

Hear insights from clinicians and a parent’s experience.

Listen now👇
https://t.co/V29LhjwY6F

[NICE @NICEComms]

Thousands of people living with a chronic liver condition are set to benefit from a new daily pill that tackles both the disease itself and the persistent, severe itching it causes.

Find out more about seladelpar: https://t.co/ZOklHdwxLR

[NICE @NICEComms]

NICE has recommended mirvetuximab soravtansine for NHS patients with platinum-resistant ovarian cancer.

The first new treatment recommended for this condition in over 20 years.

Learn more: https://t.co/o1YXNTehIr

[NICE @NICEComms]

The first immunotherapy for people with an aggressive form of stomach cancer has been recommended in final guidance published today.

Durvalumab is recommended for over 1,500 people a year: https://t.co/lrwEKs6mhz

[NICE @NICEComms]

Around 670 people living with a serious type of high blood pressure that affects the lungs can now benefit from a new treatment option.

Read our guidance on sotatercept for treating pulmonary arterial hypertension here:
https://t.co/jBROj1du9b

[NICE @NICEComms]

Women with type 1 diabetes who are pregnant or planning a baby should be offered a pregnancy-specific 'artificial pancreas' device.

It automatically monitors blood sugar and delivers insulin, reducing the need for regular finger prick tests.

Read more: https://t.co/HZuLfchFgs

[NICE @NICEComms]

Pleased to be working with @CVDPREVENTaudit on this important collaboration.

[CVDPREVENT @CVDPREVENTaudit]

‍The CVDPREVENT Audit is pleased to announce a new collaboration agreement with the National Institute for Health and Care Excellence, marking a key step forward in strengthening cardiovascular disease prevention across healthcare systems in England. @NICEComms #NICE #CVDPREVENT

[NICE @NICEComms]

No two products are the same, so no two NICE Advice projects should be either. Andrew Walsh explains how our NICE Advice service builds flexibility into everything it does and why the right approach always starts with a conversation. 💡🔗 https://t.co/0st6VsFRim

[NICE @NICEComms]

We're at #NHSConfed2026 next week!

Catch our experts on two day 1 panels: medicines policy in the new NHS operating model, and getting innovation from research to real-world adoption.

Find us at stand B19.

[NICE @NICEComms]

Health and care professionals, stay updated with NICE's latest guidelines via our WhatsApp updates channel.

📱On mobile? Join here: https://t.co/xxeOwkx9RB

🖥️On desktop? Scan the QR code in the video.

🔔Once subscribed hit the bell to stay notified.

[NICE @NICEComms]

View NICE's priority topics for 2026-27 here: https://t.co/mJOAahVvdZ

[NICE @NICEComms]

Our forward view sets out the areas we will prioritise each year.

This year we’ve added a new section highlights the strategic areas we’ll be focusing on in guidance development, such as:

✅the 10 Year Health Plan
✅the modern service frameworks
✅biosimilars and generics